Jessica S. Carey > Paul, Weiss, Rifkind, Wharton & Garrison LLP > New York, United States > Lawyer Profile

Paul, Weiss, Rifkind, Wharton & Garrison LLP  is particularly noted for its transactional capabilities and excellent contentious work, spanning class actions, regulatory investigations, and sanctions. In New York, Jonathan H. Ashtor focuses on the technology and intellectual property aspects of major transactions, while Jessica Carey handles litigious matters, including investigations and federal lawsuits involving the SEC and other agencies. In San Francisco, Meredith Dearborn is experienced in high-stakes commercial disputes for tech companies and in matters involving antitrust issues. In Washington DC, Roberto J. Gonzalez leverages his experience at the and the Consumer Financial Protection Bureau to advise financial services clients on sanctions, AML, and consumer financial protection regulation.

Paul, Weiss, Rifkind, Wharton & Garrison LLP boasts a stellar client roster for which it handles highly challenging regulatory investigations, enforcement proceedings and private actions. The team prides itself in tackling high-value securities and antitrust litigations arising from major financial crises and regulatory overhauls. Brad Karp, Jessica Carey and Ted Wells lead the practice from New York, whilst Kannon Shanmugam operates from Washington DC. Karp has an enviable record of success representing global financial institutions in high-value litigation and regulatory investigations. Carey is also a reputable litigator within the financial services industry, handling complex securities and commercial matters in federal and state courts. Other key players include Susanna Buergel, who co-chairs the securities defense practice, and prolific securities litigator Daniel Kramer, both based in New York.

Paul, Weiss, Rifkind, Wharton & Garrison LLP offers strategic legal counsel to companies and executives facing federal and state regulatory enforcement. Known for their ability to prevent and respond to government investigations, the firm excels in handling matters before the DOJ, SEC, and other agencies. The firm has significant experience in antitrust, anti-corruption and FCPA issues, securities litigation, and financial services investigations. Brad Karp , based in New York, represents Fortune 100 companies and other entities in critical regulatory matters and internal investigations. Jessica Carey, also in New York, specializes in sensitive criminal and regulatory litigation, particularly for financial institutions. Roberto Finzi focuses on regulatory investigations, while Melinda Haag  has deep experience in complex white-collar cases. Lorin L. Reisner and Richard C. Tarlowe bring deep expertise in representing senior executives and corporations in high-stakes investigations. Loretta Lynch boasts experience in advising clients on complex government and internal investigations.

Paul, Weiss, Rifkind, Wharton & Garrison LLP‘s team is skilled at delivering oral arguments before federal courts of appeals. Standout mandates of late have included securing an August 2023 Second Circuit victory on behalf of Goldman Sachs in a $13bn securities class action; and representing SAP in an appeal of antitrust and trade secrets claims brought by business analytics database provider Teradata. Kannon Shanmugam, who is lauded as ‘truly outstanding’ and a ‘world-class appellate litigator’, co-heads the group. Brad Karp and Jessica Carey co-lead alongside him. William Marks is an additional key contact; he specializes in civil and criminal appeals in federal and state courts and draws on experience representing clients in fifteen merits cases at the U.S. Supreme Court. Shanmugam and Marks recently won a notable appellate victory for Carnival Corporation when the Eleventh Circuit reversed a $440m judgment under the Helms-Burton Act for the allegedly improper use of docks in Havana that were seized by Fidel Castro’s government following the Cuban Revolution. Karen Dunn has departed the team.

Paul, Weiss, Rifkind, Wharton & Garrison LLP handles the full spectrum of tech and life sciences patent disputes, spanning jury and bench trials as well as appeals at the Federal Circuit. The department is further distinguished by its ‘top-notch’ antitrust and trade secret offering. In New York, the team is co-chaired by Brad Karp, Jessica Carey and Catherine Nyarady. Nyarady is a prominent patent litigator with expertise in medical devices, semiconductors and pharma. In Washington DC, Kannon Shanmugam, a leading appellate litigator, chairs the team. Elizabeth Stotland Weiswasser frequently takes on the role of lead counsel in high-stakes pharma and biotech patent disputes, while Katherine Forrest handles patent and antitrust litigation related to AI, cryptocurrency and blockchain. Crystal Parker brings valuable expertise in Hatch-Waxman litigation, biologics and medical devices. Additionally, Kripa Raman further strengthens the team’s capabilities with his experience in patent and trade secret litigation. Karen Dunn, Bill Isaacson, and Jeannie S. Rhee have departed the firm.